Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,594 | -7,394 | -701 | -108,779 | -92,690 |
| Depreciation Amortization | 7,112 | 7,422 | 2,446 | 85,478 | 72,307 |
| Accounts receivable | -12,335 | -3,834 | -6,212 | 6,533 | 647 |
| Accounts payable and accrued liabilities | N/A | -838 | N/A | N/A | N/A |
| Other Working Capital | -8,257 | -12,545 | -10,083 | -10,863 | -4,651 |
| Other Operating Activity | 13,580 | 5,601 | 5,402 | -1,192 | 2,659 |
| Operating Cash Flow | $-14,494 | $-11,588 | $-9,148 | $-28,823 | $-21,728 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 38 | 37 | 42 | -3,248 | -3,207 |
| Investing Cash Flow | $38 | $37 | $42 | $-3,248 | $-3,207 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 6,590 | 3,616 | 4,274 | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 15,000 | 15,000 |
| Debt Repayment | -4,190 | -2,433 | -327 | -20,510 | -19,352 |
| Common Stock Issued | 13,012 | 11,573 | 10,416 | 11,694 | 12,700 |
| Other Financing Activity | -1,137 | -1,064 | -806 | -4,654 | -5,701 |
| Financing Cash Flow | $14,275 | $11,692 | $13,557 | $1,530 | $2,647 |
| Beginning Cash Position | 19,360 | 19,360 | 19,360 | 49,901 | 49,901 |
| End Cash Position | 19,179 | 19,501 | 23,811 | 19,360 | 27,613 |
| Net Cash Flow | $-181 | $141 | $4,451 | $-30,541 | $-22,288 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,494 | -11,588 | -9,148 | -28,823 | -21,728 |
| Free Cash Flow | -14,494 | -11,588 | -9,148 | -28,823 | -21,728 |